Regenxbio and AbbVie Inc Agreement. See Also: Gilead Sciences and Everest Medicines News

Impacting News November 12, 2021

Regenxbio and AbbVie Inc Agreement
Regenxbio (RGNX) announced the successful closure of the collaboration and license agreement with AbbVie Inc (This content is for paid subscribers.

Please click here to subscribe or here to log in.

Impacting News
AbbVie Inc (ABBV), Everest Medicines, Gilead Sciences (GILD), Regenxbio (RGNX)
November 12, 2021

Tweet Pin It

Other Articles

Vertex Pharmaceuticals Presents Positive Data for Zimislecel in Type1 Diabetes at the American Diabetes Association 85th Scientific Sessions

June 26, 2025 0

Cidara Therapeutics Announces Positive Topline Results From Phase 2b Navigate Trial evaluating CD388 – A Nonvaccine Preventative of Seasonal Influenza

June 24, 2025 0

Exelixis Announces Zanzalintinib in Combination with an Immune Checkpoint Inhibitor Improved Overall Survival in Patients with Metastatic Colorectal Cancer

June 23, 2025 0

Why Many Biotech Investors Believe Akero Therapeutics Will Soon Be Acquired By A Top-Tier Company

May 23, 2025 0

Search ProhostBiotech

Popular Links
Aerie Pharmaceuticals (AERI) Agenus (AGEN) Alnylam Pharmaceuticals (ALNY) Amgen (AMGN) Array BioPharma (ARRY) AstraZeneca Plc (AZN) Bellicum Pharmaceuticals Inc (BLCM) Bristol-Myers Squibb (BMY) Celgene (CELG) Celldex Therapeutics (CLDX) Cellectis (CLLS) Celyad (CYAD) Compugen (CGEN) CRISPR Therapeutics (CRSP) CytomX Therapeutics Inc (CTMX) Editas Medicine Inc (EDIT) Enanta Pharmaceuticals (ENTA) Exelixis (EXEL) Gilead Sciences (GILD) Halozyme Therapeutics (HALO) Illumina (ILMN) ImmunoGen (IMGN) Incyte (INCY) Innoviva (INVA) Intellia Therapeutics (NTLA) Ionis Pharmaceuticals Inc (IONS) Karyopharm Therapeutics Inc (KPTI) Merck (MRK) Moderna Inc (MRNA) Nektar Therapeutics (NKTR) Neurocrine Biosciences (NBIX) Novartis (NVS) Portola Pharmaceuticals Inc (PTLA) PTC Therapeutics (PTCT) Regeneron Pharmaceuticals (REGN) Regenxbio (RGNX) Rhythm Pharmaceuticals Inc (RYTM) Sangamo Therapeutics Inc (SGMO) Sarepta Therapeutics (SRPT) Seagen Inc (SGEN) Spark Therapeutics Theravance Biopharma (TBPH) Vertex Pharmaceuticals (VRTX) Xoma (XOMA)

Recent

ProhostBiotech Archive
ProhostBiotech Archive
Sign Up for Weekly Emails
First Name

Last Name

Email address:

Prohost Biotech – Exclusive Biotech Research Copyright © 2025.
© 2014 Prohost Biotech. All rights reserved.
Privacy Policy | Cancellation Policy | Forward Looking Statement

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Accept Privacy policy

Exclusive Market Insight

& Scientific analysis

Regenxbio and AbbVie Inc Agreement. See Also: Gilead Sciences and Everest Medicines News